Anuncio
Mercados españoles cerrados
  • IBEX 35

    11.154,60
    +170,90 (+1,56%)
     
  • Euro Stoxx 50

    5.006,85
    +67,84 (+1,37%)
     
  • Dólar/Euro

    1,0693
    -0,0040 (-0,37%)
     
  • Petróleo Brent

    89,59
    +0,58 (+0,65%)
     
  • Oro

    2.348,30
    +5,80 (+0,25%)
     
  • Bitcoin EUR

    59.390,54
    -471,54 (-0,79%)
     
  • CMC Crypto 200

    1.321,87
    -74,66 (-5,35%)
     
  • DAX

    18.161,01
    +243,73 (+1,36%)
     
  • FTSE 100

    8.139,83
    +60,97 (+0,75%)
     
  • S&P 500

    5.102,31
    +53,89 (+1,07%)
     
  • Dow Jones

    38.253,81
    +168,01 (+0,44%)
     
  • Nasdaq

    15.925,47
    +313,71 (+2,01%)
     
  • Petróleo WTI

    84,07
    +0,50 (+0,60%)
     
  • EUR/GBP

    0,8565
    -0,0008 (-0,10%)
     
  • Plata

    27,28
    -0,07 (-0,27%)
     
  • NIKKEI 225

    37.934,76
    +306,28 (+0,81%)
     

Global Medical and Recreational Cannabis Market Overview 2022: Regulatory Data on Medical and Recreational Cannabis in Over 57 Jurisdictions

Company Logo
Company Logo

Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Medical and Recreational Cannabis - A Global Overview" report has been added to ResearchAndMarkets.com's offering.

CBD-Intel has compiled and classified the regulatory data on medical and recreational cannabis in over 57 jurisdictions around the world. The following report, accompanied by a more detailed database, provides an overview of the regulatory situation in the selected countries using maps, and assesses the likelihood that the status quo may change in the future.

Key Topics Covered:

1 Introduction

2 Medical Cannabis

3 Recreational Cannabis

4 CBD Regulated As A Medicine

5 Methodology

For more information about this report visit https://www.researchandmarkets.com/r/t6s80j

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900